PURPOSE: Glaucoma is a complex disease involving multiple genetic factors. Recently, single nucleotide polymorphisms (SNPs) in the LOXL1 gene have been implicated in exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) but not in the primary glaucomas. This study was conducted to determine the possible involvement of these SNPs in cases of primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG). METHODS: The three associated SNPs of LOXL1 (rs1048661, rs3825942, and rs2165241) were screened in 208 unrelated and clinically well-characterized glaucoma cases comprising patients with POAG (n = 112) or PACG (n = 96) along with 105 ethnically matched normal control subjects from Indian populations. Subjects with exfoliative material on the lens and radial pigmentation in the periphery of the lens that could be earlier signs of XFS were excluded. These SNPs were screened by resequencing and further confirmed by PCR-based restriction digestions. Haplotypes were generated with the three SNPs in cases and control subjects, and linkage disequilibrium (LD) and haplotype analysis were performed with the Haploview software, which uses the EM (expectation-maximization) algorithm. RESULTS: The SNPs of LOXL1 did not exhibit any significant association with POAG or PACG, unlike previous studies from Icelandic, Swedish, U.S., and Australian populations with XFS/XFG. Haplotypes generated with these intragenic SNPs did not indicate any significant risk with POAG or PACG phenotypes. The risk haplotype G-G in XFS/XFG in other populations was present in 46% of the normal control subjects in the present cohort. CONCLUSIONS: The results from the present study do not indicate the involvement of the LOXL1 SNPs in POAG and PACG.
PURPOSE:Glaucoma is a complex disease involving multiple genetic factors. Recently, single nucleotide polymorphisms (SNPs) in the LOXL1 gene have been implicated in exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) but not in the primary glaucomas. This study was conducted to determine the possible involvement of these SNPs in cases of primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG). METHODS: The three associated SNPs of LOXL1 (rs1048661, rs3825942, and rs2165241) were screened in 208 unrelated and clinically well-characterized glaucoma cases comprising patients with POAG (n = 112) or PACG (n = 96) along with 105 ethnically matched normal control subjects from Indian populations. Subjects with exfoliative material on the lens and radial pigmentation in the periphery of the lens that could be earlier signs of XFS were excluded. These SNPs were screened by resequencing and further confirmed by PCR-based restriction digestions. Haplotypes were generated with the three SNPs in cases and control subjects, and linkage disequilibrium (LD) and haplotype analysis were performed with the Haploview software, which uses the EM (expectation-maximization) algorithm. RESULTS: The SNPs of LOXL1 did not exhibit any significant association with POAG or PACG, unlike previous studies from Icelandic, Swedish, U.S., and Australian populations with XFS/XFG. Haplotypes generated with these intragenic SNPs did not indicate any significant risk with POAG or PACG phenotypes. The risk haplotype G-G in XFS/XFG in other populations was present in 46% of the normal control subjects in the present cohort. CONCLUSIONS: The results from the present study do not indicate the involvement of the LOXL1 SNPs in POAG and PACG.
Authors: Khaled K Abu-Amero; Essam A Osman; Mohammad T Azad; R Rand Allingham; Michael A Hauser; Saleh A Al-Obeidan Journal: Ophthalmic Genet Date: 2011-04-21 Impact factor: 1.803
Authors: Haoyu Chen; Li Jia Chen; Mingzhi Zhang; Weifeng Gong; Pancy Oi Sin Tam; Dennis Shun Chiu Lam; Chi Pui Pang Journal: Mol Vis Date: 2010-02-06 Impact factor: 2.367
Authors: Wen Sun; Yan Sheng; Yu Weng; Chun-Xiao Xu; Susan E I Williams; Yu-Tao Liu; Michael A Hauser; R Rand Allingham; Ming-Juan Jin; Guang-Di Chen Journal: Int J Ophthalmol Date: 2014-06-18 Impact factor: 1.779
Authors: Yutao Liu; Silke Schmidt; Xuejun Qin; Jason Gibson; Kristen Hutchins; Cecile Santiago-Turla; Janey L Wiggs; Donald L Budenz; Stephen Akafo; Pratap Challa; Leon W Herndon; Michael A Hauser; R Rand Allingham Journal: Invest Ophthalmol Vis Sci Date: 2008-04-17 Impact factor: 4.799
Authors: Kelvin Y C Lee; Su Ling Ho; Anbupalam Thalamuthu; Anandalakshmi Venkatraman; Divya Venkataraman; Don C K Pek; Tin Aung; Eranga N Vithana Journal: Mol Vis Date: 2009-06-04 Impact factor: 2.367
Authors: Wei Fen Gong; Sylvia W Y Chiang; Li Jia Chen; Pancy O S Tam; Li Yun Jia; Dexter Y L Leung; Yi Qun Geng; Clement C Y Tham; Dennis S C Lam; Robert Ritch; Ningli Wang; Chi Pui Pang Journal: Mol Vis Date: 2008-12-19 Impact factor: 2.367